Here are four observations:
1. The implants are knee prosthesis components for orthopedic surgery.
2. DePuy Orthopaedics is recalling the implants because they have higher rates of revision in Australia when the native patella is not resurfaced when compared to other unresurfaced PS implants.
3. If the system is implanted and the native patella is not resurfaced, the patient may experience patello-femoral pain, and may potentially require a secondary procedure.
4. The system has been distributed in countries worldwide, including China, Belgium, France, Australia and South Africa.
More articles on devices:
Boston Scientific launches Precision Novi SCS in Europe — 5 key notes
Zimmer, Centinel Spine, Mazor Robotics & more — 14 key notes
BioMedical Enterprises launches nitinol bone fixation implant: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
